Overview The Effect of MK0633 in Patients With Chronic Asthma (0633-007) Status: Terminated Trial end date: 2009-06-01 Target enrollment: Participant gender: Summary A clinical study to evaluate the efficacy and safety of MK0633 in adult patients with chronic asthma. Phase: Phase 2 Details Lead Sponsor: Merck Sharp & Dohme Corp.